Literature DB >> 6488037

Striatal dopamine release stimulated by amphetamine or potassium: influence of ovarian hormones and the light-dark cycle.

J B Becker, M E Beer, T E Robinson.   

Abstract

The release of endogenous dopamine (DA) from rat striatal tissue was studied in an in vitro superfusion system following hormonal manipulations in vivo. Progesterone treatment in estrogen-primed ovariectomized female rats potentiated DA release stimulated either by amphetamine or potassium (K+). In addition, the amount of striatal DA released in response to K+-stimulation was influenced by the light-dark cycle. We conclude that striatal DA release is modulated by ovarian hormones, and suggest that ovarian hormone modulation of presynaptic striatal DA activity may contribute to well-known estrous cycle dependent variations in some non-reproductive behaviors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6488037     DOI: 10.1016/0006-8993(84)91410-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

Review 1.  Psychotropic properties of ovarian estrogens (review).

Authors:  E B Arushanyan; G K Borovkova
Journal:  Neurosci Behav Physiol       Date:  1989 Jan-Feb

2.  Preventative treatment in an animal model of ADHD: Behavioral and biochemical effects of methylphenidate and its interactions with ovarian hormones in female rats.

Authors:  Jodi L Lukkes; Nadja Freund; Britta S Thompson; Shirisha Meda; Susan L Andersen
Journal:  Eur Neuropsychopharmacol       Date:  2016-07-05       Impact factor: 4.600

Review 3.  Rapid effects of ovarian hormones in dorsal striatum and nucleus accumbens.

Authors:  Katie E Yoest; Jacqueline A Quigley; Jill B Becker
Journal:  Horm Behav       Date:  2018-04-22       Impact factor: 3.587

4.  Impact of pubertal and adult estradiol treatments on cocaine self-administration.

Authors:  Adam N Perry; Christel Westenbroek; Jill B Becker
Journal:  Horm Behav       Date:  2013-09-05       Impact factor: 3.587

5.  Natural and synthetic estrogens specifically alter nicotine demand and cue-induced nicotine seeking in female rats.

Authors:  Erin E Maher; Paula F Overby; Amanda H Bull; Joshua S Beckmann; Jonna M Leyrer-Jackson; Stephanie V Koebele; Heather A Bimonte-Nelson; Cassandra D Gipson
Journal:  Neuropharmacology       Date:  2021-08-17       Impact factor: 5.273

6.  Evidence for the involvement of ERbeta and RGS9-2 in 17-beta estradiol enhancement of amphetamine-induced place preference behavior.

Authors:  Jill L Silverman; James I Koenig
Journal:  Horm Behav       Date:  2007-03-31       Impact factor: 3.587

7.  Time-of-day differences in dopamine clearance in the rat medial prefrontal cortex and nucleus accumbens.

Authors:  Evan P Sleipness; Heiko T Jansen; James O Schenk; Barbara A Sorg
Journal:  Synapse       Date:  2008-12       Impact factor: 2.562

Review 8.  Sex differences in dopamine release regulation in the striatum.

Authors:  Jennifer E Zachry; Suzanne O Nolan; Lillian J Brady; Shannon J Kelly; Cody A Siciliano; Erin S Calipari
Journal:  Neuropsychopharmacology       Date:  2020-12-14       Impact factor: 7.853

9.  Aging reduces the sensitivity to the reinforcing efficacy of morphine.

Authors:  Angela R Bongiovanni; Kyle Peer; Rachel E Carpenter; Alexandra S Ellis; Michael R Duggan; Vinay Parikh; Mathieu E Wimmer
Journal:  Neurobiol Aging       Date:  2020-10-01       Impact factor: 4.673

10.  Sex and estrogens alter the action of glucagon-like peptide-1 on reward.

Authors:  Jennifer E Richard; Rozita H Anderberg; Lorena López-Ferreras; Kajsa Olandersson; Karolina P Skibicka
Journal:  Biol Sex Differ       Date:  2016-01-16       Impact factor: 5.027

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.